Suzanne Quinn Martinez
Suzanne Quinn Martinez publishes mostly in Endocrinology, Diabetes and Metabolism, Molecular Biology and Neurology, on topics such as Diabetes Management and Research, Diabetes Treatment and Management and Hyperglycemia and glycemic control in critically ill and hospitalized patients.
- World rank
- #6,364,284 of 7,710,434 ranked researchers
- Rank in United States
- #1,509,035 of 1,627,098
- Works
- 16
- Citations
- 20
- Citations per work
- 1.3
What does Suzanne Quinn Martinez research?
Suzanne Quinn Martinez's work is mostly in Medicine (69%), Biochemistry, Genetics and Molecular Biology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1169.3%
- Medicine1169.3%
- Everything else320.4%
- Life Sciences210.3%
- 1Endocrinology, Diabetes and Metabolism38% of their works
- 2Molecular Biology10% of their works
- 3Neurology8% of their works
- 4Pulmonary and Respiratory Medicine8% of their works
- 5Epidemiology8% of their works
- 6Surgery8% of their works
Research topics
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Neuroendocrine Tumor Research Advances
- Metabolism, Diabetes, and Cancer
- Thyroid Cancer Diagnosis and Treatment
- Advanced Glycation End Products research
- Diabetes and associated disorders
Which keywords describe Suzanne Quinn Martinez's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Diabetes, Type 1 Diabetes, Cardiovascular Outcomes, Continuous Glucose Monitoring, Critical Care and Hyperglycemia.
- HMGB1
- Autoimmunity
- Thyroid Nodules
- Differentiated Thyroid Cancer
- Type 2 Diabetes
- Neuroendocrine Tumors
- Hyperglycemia
- Continuous Glucose Monitoring
- Type 1 Diabetes
- Insulin Therapy
- Glycemic Control
- Diabetes
- Cardiovascular Outcomes
- Critical Care
- Hypoglycemia
- Pancreatic Neuroendocrine Tumors
- AMP-Activated Protein Kinase
- Metformin
- Advanced Glycation End Products
- Genetics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Glycemic Control93 topics
- Insulin Therapy93 topics
- Diabetes42 topics
- Type 1 Diabetes42 topics
- Cardiovascular Outcomes31 topic
- Continuous Glucose Monitoring31 topic
- Critical Care31 topic
- Hyperglycemia31 topic
- Hypoglycemia31 topic
- Neuroendocrine Tumors31 topic
- Pancreatic Neuroendocrine Tumors31 topic
- Type 2 Diabetes31 topic
- AMP-Activated Protein Kinase21 topic
- Differentiated Thyroid Cancer21 topic
- Metformin21 topic
- Thyroid Nodules21 topic
- Advanced Glycation End Products11 topic
- Autoimmunity11 topic
- Genetics11 topic
- HMGB111 topic
Where does Suzanne Quinn Martinez work?
Suzanne Quinn Martinez's main affiliation in the publication record is Park Avenue Dermatology, United States.
How many publications and citations does Suzanne Quinn Martinez have?
OpenAlex counts 16 works and 20 citations for Suzanne Quinn Martinez, an h-index of 2, ranking #6,364,284 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Suzanne Quinn Martinez. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.